NeuroOne Medical Technologies Corporation Revenue from Contract with Customer, Including Assessed Tax
NeuroOne Medical Technologies Corporation (NMTC) reported Revenue from Contract with Customer, Including Assessed Tax of $1.86 million for the 3-month period ending 2026-03-31, per its 10-Q/A filed 2026-06-12.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-06-12
- NeuroOne Medical Technologies Corporation revenue from contract with customer, including assessed tax for the quarter ending 2026-03-31 was $1.86M.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month |
|---|---|---|
| 2026-03-31 | $1.86M 10-Q/A · filed 2026-06-12 | $4.75M 10-Q/A · filed 2026-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |